Variant report
Variant | nsv1046806 |
---|---|
Chromosome Location | chr14:41815453-41858094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:121)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr14:41852997-41853203 | K562 | blood: | n/a | n/a |
2 | ATF3 | chr14:41831395-41831637 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | BACH1 | chr14:41853134-41853209 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CEBPB | chr14:41855036-41855437 | ECC-1 | luminal epithelium: | n/a | n/a |
5 | CEBPB | chr14:41843283-41843667 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr14:41843330-41843647 | A549 | lung: | n/a | n/a |
7 | CEBPB | chr14:41843358-41843671 | IMR90 | lung: | n/a | n/a |
8 | CEBPB | chr14:41843343-41843675 | MCF-7 | breast: | n/a | n/a |
9 | CEBPB | chr14:41825972-41826222 | HepG2 | liver: | n/a | chr14:41826057-41826068 |
10 | CEBPB | chr14:41843406-41843570 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | CTCF | chr14:41842640-41842790 | HepG2 | liver: | n/a | n/a |
12 | E2F4 | chr14:41823575-41823730 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | E2F4 | chr14:41846643-41846843 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | EP300 | chr14:41853549-41854377 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | EP300 | chr14:41854870-41855547 | ECC-1 | luminal epithelium: | n/a | chr14:41855125-41855132 |
16 | EP300 | chr14:41854836-41855553 | ECC-1 | luminal epithelium: | n/a | chr14:41855125-41855132 |
17 | ESR1 | chr14:41854946-41855497 | ECC-1 | luminal epithelium: | n/a | n/a |
18 | ESR1 | chr14:41854969-41855441 | ECC-1 | luminal epithelium: | n/a | n/a |
19 | ESR1 | chr14:41854986-41855469 | ECC-1 | luminal epithelium: | n/a | n/a |
20 | ESR1 | chr14:41854941-41855476 | ECC-1 | luminal epithelium: | n/a | n/a |
21 | ESR1 | chr14:41854989-41855495 | ECC-1 | luminal epithelium: | n/a | n/a |
22 | FOS | chr14:41817955-41818281 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr14:41831453-41831572 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr14:41817971-41818266 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOS | chr14:41817991-41818263 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | FOS | chr14:41831411-41831691 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOXM1 | chr14:41854682-41855573 | ECC-1 | luminal epithelium: | n/a | n/a |
28 | FOXM1 | chr14:41854764-41855635 | ECC-1 | luminal epithelium: | n/a | n/a |
29 | GATA2 | chr14:41838616-41838910 | SH-SY5Y | brain: | n/a | n/a |
30 | GATA3 | chr14:41817162-41817412 | SH-SY5Y | brain: | n/a | n/a |
31 | GATA3 | chr14:41829001-41829669 | MCF-7 | breast: | n/a | chr14:41829248-41829257 chr14:41829223-41829232 chr14:41829250-41829257 chr14:41829225-41829235 |
32 | JUN | chr14:41843365-41843665 | HepG2 | liver: | n/a | chr14:41843499-41843512 |
33 | JUN | chr14:41849449-41849529 | H1-hESC | embryonic stem cell: | n/a | n/a |
34 | JUN | chr14:41849257-41849609 | HepG2 | liver: | n/a | chr14:41849427-41849440 chr14:41849428-41849437 |
35 | JUND | chr14:41849248-41849619 | HepG2 | liver: | n/a | chr14:41849428-41849437 |
36 | JUND | chr14:41837472-41837756 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | JUND | chr14:41843325-41843683 | HepG2 | liver: | n/a | n/a |
38 | MAFF | chr14:41824202-41824376 | HepG2 | liver: | n/a | chr14:41824262-41824280 |
39 | MAFK | chr14:41828604-41828657 | HepG2 | liver: | n/a | chr14:41828632-41828647 |
40 | MAFK | chr14:41828566-41828639 | HepG2 | liver: | n/a | n/a |
41 | MAFK | chr14:41850478-41850509 | HepG2 | liver: | n/a | n/a |
42 | MAX | chr14:41855120-41855387 | ECC-1 | luminal epithelium: | n/a | n/a |
43 | MAX | chr14:41831360-41831688 | H1-hESC | embryonic stem cell: | n/a | n/a |
44 | MAX | chr14:41831312-41831737 | MCF-7 | breast: | n/a | n/a |
45 | MAX | chr14:41831347-41831679 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | MAX | chr14:41831385-41831700 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | MYC | chr14:41819850-41819965 | MCF-7 | breast: | n/a | n/a |
48 | MYC | chr14:41819754-41819993 | MCF-7 | breast: | n/a | n/a |
49 | MYC | chr14:41819746-41819847 | MCF-7 | breast: | n/a | n/a |
50 | MYC | chr14:41831377-41831691 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:41856073..41858584-chr14:41859093..41860987,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000221695 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377047399 | chr14:41817166-41817167 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs117842894 | chr14:41817174-41817175 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs192604710 | chr14:41817191-41817192 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs71409999 | chr14:41817242-41817243 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs28657626 | chr14:41817263-41817264 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs369914018 | chr14:41817297-41817298 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs554210784 | chr14:41817360-41817361 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs71440734 | chr14:41817370-41817371 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs398118112 | chr14:41817377-41817378 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs150719931 | chr14:41817394-41817395 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs138995653 | chr14:41817433-41817434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117225853 | chr14:41817505-41817506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145018182 | chr14:41817542-41817543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183357449 | chr14:41817551-41817552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs8008330 | chr14:41817569-41817570 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs147601123 | chr14:41817635-41817636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs8007175 | chr14:41817660-41817661 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs560182480 | chr14:41817683-41817684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555366064 | chr14:41817686-41817687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529359545 | chr14:41817715-41817716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116845961 | chr14:41817724-41817725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187722732 | chr14:41817766-41817767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571020302 | chr14:41817787-41817788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538535889 | chr14:41817816-41817817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556553593 | chr14:41817851-41817852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75124594 | chr14:41817870-41817871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535857829 | chr14:41817879-41817880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554273876 | chr14:41817918-41817919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs8011741 | chr14:41817982-41817983 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs577778086 | chr14:41818055-41818056 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs558334210 | chr14:41818063-41818064 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs576934144 | chr14:41818073-41818074 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs142040266 | chr14:41818080-41818081 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs562623777 | chr14:41818117-41818118 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs530134329 | chr14:41818141-41818142 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs542239811 | chr14:41818193-41818194 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs560606822 | chr14:41818268-41818269 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs527793065 | chr14:41818323-41818324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552660227 | chr14:41818331-41818332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201626305 | chr14:41818339-41818340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112013893 | chr14:41818340-41818341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532020508 | chr14:41818346-41818347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191445379 | chr14:41818391-41818392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550485130 | chr14:41818410-41818411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568639560 | chr14:41818424-41818425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114396542 | chr14:41818428-41818429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184204173 | chr14:41818495-41818496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566084342 | chr14:41818513-41818514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533662782 | chr14:41818524-41818525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144858283 | chr14:41818530-41818531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:41817200-41818600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr14:41817200-41818800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr14:41818400-41819000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr14:41819400-41820000 | ZNF genes & repeats | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr14:41819800-41820000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr14:41824400-41825800 | Enhancers | Fetal Lung | lung |
7 | chr14:41837200-41837400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr14:41837400-41837600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr14:41837400-41837600 | Flanking Bivalent TSS/Enh | Breast Myoepithelial Primary Cells | Breast |
10 | chr14:41855000-41855400 | Enhancers | Cortex derived primary cultured neurospheres | brain |